西妥昔单抗和贝伐单抗在晚期结直肠癌一二线治疗中的研究进展(4)
[12] Iwamoto S，Hazama S，Kato T，et al. Multicenter phase II study of second-line cetuximab plas folinic acid/5-fluoroura-cil/irinotecan(FOLFIRI)in KRAS wild-type metastatic colorectal cancer：the FLIER study [J]. Anticancer Res，2014，34(14)：1967-1973.[13] Samelis GF，Ekmektzoglou KA，Tsiakou A，et al. The continuation of bevacizumab following disease progression in patients with metastatic colorectal cancer offers a survival benefit [J]. Hepatogastroenterology ......
您现在查看是摘要页，全文长 3481 字符。